• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

VNLPF:US

0.5250 USD 0.00000.00%

As of 20:10:00 ET on 07/17/2014.

Snapshot for Vernalis PLC (VNLPF)

Open: - Day's Range: - Volume: 694
Previous Close: 0.5250 52wk Range: 0.5250 - 0.6550 1-Yr Rtn: -

Stock Chart for VNLPF

No chart data available.
  • VNLPF:US 0.5250
  • 1D
  • 1M
  • 1Y
0.5250
Interactive VNLPF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for VNLPF

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (GBP) (ttm) -
Est. EPS (GBP) (12/2014) -0.0200
Est. PEG Ratio -
Market Cap (M USD) 232.19
Shares Outstanding (M) 442.27
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/01/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for VNLPF

  • Revenue
  • Net Income (M/GBP)
  • Profit Margin (%)

Company Profile & Key Executives for VNLPF

Vernalis plc is a revenue generating development stage pharmaceutical company which has a broad pipeline of research and development programs. The Company is focused on developing products for the US prescription cough and cold market. The Company derives pipeline candidates both from collaborations with global pharmaceutical businesses and their own research activities.

Ian GarlandChief Executive OfficerDavid MackneyChief Financial Officer
Kevin KissaneSecretary
More Company Profile & Key Executives for VNLPF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil